Filing metadata

Accession number
0001209191-22-057983
Form type
Form 4
Filer
BridgeBio Pharma, Inc.
CIK
CIK 1743881
Filed
Nov 18, 2022
Reporting period
Nov 16, 2022
Description
Insider transaction

Explore SEC Filings Hub